Summary of Key Points Core Viewpoint The company, Shandong Linuo Pharmaceutical Packaging Co., Ltd., has decided to change the use of part of the raised funds from its convertible bond issuance to better align with its current development needs and strategic planning. Group 1: Fundraising Overview - The company issued 5 million convertible bonds with a total fundraising amount of 500 million RMB, netting 491.44 million RMB after deducting fees [1][2] - The original project for the raised funds was the industrialization of lightweight pharmaceutical molded glass bottles, with a total investment of 641.87 million RMB [2][4] - As of August 10, 2025, 126.05 million RMB of the raised funds had been utilized, leaving an unused amount [2][4] Group 2: Change in Fund Usage - The company plans to reallocate 154 million RMB from the original project to two new projects: acquiring a 30% stake in Chuangyang Co. and the second phase of the high-end pharmaceutical packaging project [2][5] - The new projects include an investment of 84 million RMB for the acquisition and 70 million RMB for the high-end packaging project [2][5] Group 3: Rationale for Change - The original project faced delays due to late delivery of construction facilities and lengthy customer certification processes, leading to a reduced funding requirement [4][5] - The company received a government subsidy of 89.58 million RMB for the original project, further decreasing the need for raised funds [4][5] Group 4: New Investment Projects - The acquisition of a 30% stake in Chuangyang Co. aims to enhance the company's product offerings and market share in pharmaceutical packaging [5][8] - The second phase of the high-end packaging project focuses on RTU (Ready-to-Use) packaging and pre-filled syringes, with a total investment of 383.37 million RMB [9][10] - The project is expected to have a payback period of 6.82 years and an internal rate of return of 16.37% [9] Group 5: Strategic Importance - The new projects align with the growing demand for high-quality pharmaceutical packaging driven by trends in the pharmaceutical industry [10][11] - The company aims to transition from a traditional pharmaceutical glass manufacturer to a diversified high-end packaging solution provider [10][12] - The strategic shift is supported by national policies promoting the development of the pharmaceutical packaging industry [13][14] Group 6: Approval Process - The board of directors and the supervisory board have approved the change in fund usage, ensuring compliance with relevant regulations [16][17] - The independent directors also confirmed that the decision aligns with the company's interests and does not harm shareholder value [17][18]

Core Viewpoint - The company, Shandong Linuo Pharmaceutical Packaging Co., Ltd., is changing the use of part of the raised funds from its convertible bond issuance to better align with its strategic development needs and improve fund utilization efficiency [2][19]. Summary by Sections Fundraising Overview - The company issued 5 million convertible bonds with a net fundraising amount of RMB 491.4447 million, after deducting underwriting fees [2][3]. - As of August 10, 2025, a total of RMB 126.0511 million has been invested from the raised funds, with the remaining amount stored in dedicated bank accounts [3][5]. Change in Fund Usage - The company plans to change the use of RMB 154 million from the "Lightweight Pharmaceutical Glass Bottle (Class I) Industrialization Project" to invest in two new projects: acquiring 30% equity in Suzhou Chuangyang New Materials Technology Co., Ltd. and the second phase of the high-end pharmaceutical packaging project [3][4]. - The new projects include an investment of RMB 84 million for the equity acquisition and RMB 154 million for the high-end packaging project [3][6]. Reasons for Change - The original project faced delays due to late delivery of construction facilities and longer customer certification cycles, leading to a reduced need for the originally planned funds [5][6]. - The company received a government subsidy of RMB 89.58 million, which decreased the funding requirement for the original project [5][6]. New Investment Projects - The acquisition of 30% equity in Suzhou Chuangyang New Materials is aimed at enhancing the company's product offerings and market share in pharmaceutical packaging [6][10]. - The second phase of the high-end pharmaceutical packaging project focuses on the production of Ready-to-Use (RTU) packaging and pre-filled syringes, with a total investment of RMB 383.3725 million, of which RMB 70 million will come from the raised funds [10][11]. Impact of Changes - The changes in fund usage are expected to enhance the company's operational efficiency and long-term benefits without adversely affecting its existing business or financial status [19][20]. - The company will implement strict internal and external supervision of the fund usage to ensure compliance with relevant regulations [20][21].

Core Viewpoint - The report highlights significant growth in revenue and net profit for Kunming Chuanjin Nuo Chemical Co., Ltd. in the first half of 2025, indicating a strong financial performance and strategic investments in new projects [1][4]. Financial Performance - Operating revenue for the reporting period reached approximately CNY 1.74 billion, representing a 27.91% increase compared to the same period last year [1]. - Net profit attributable to shareholders was approximately CNY 177.50 million, marking a substantial increase of 166.51% year-on-year [1]. - The net cash flow from operating activities was approximately CNY 170.95 million, a remarkable increase of 423.23% compared to the previous year [1]. - Basic earnings per share were CNY 0.6457, up 166.49% from CNY 0.2423 in the same period last year [1]. Asset and Equity Position - Total assets at the end of the reporting period were approximately CNY 3.67 billion, reflecting a 1.66% increase from the previous year [3]. - Net assets attributable to shareholders increased to approximately CNY 2.64 billion, a rise of 3.91% year-on-year [3]. Strategic Investments - The company signed a project investment agreement with the Dongchuan District Government to construct a waste disposal project with a total investment of approximately CNY 350 million [4]. - The company approved an investment project in Egypt, which includes the production of various phosphate chemicals with an annual capacity of 800,000 tons of sulfuric acid and other related products [5][6].

Summary of Key Points Core Viewpoint The company, Jiahe Intelligent Technology Co., Ltd., is changing the use of raised funds from its convertible bond issuance to acquire all partnership interests in beyerdynamic GmbH & Co. KG, a well-known high-end audio equipment manufacturer, due to the current macroeconomic environment and market uncertainties affecting its original investment projects. Group 1: Fundraising and Investment Projects - The company raised a total of RMB 1,004 million through the issuance of 10,040,000 convertible bonds, with a net amount of RMB 993.91 million after deducting issuance costs [1][4][6] - The original investment projects included the production of 5 million bone conduction headphones, 9 million smartwatches, and 4.5 million smart glasses, which were initially planned to be operational by January 10, 2026 [4][9] - Due to changes in the macroeconomic environment and uncertainties in international trade, the company has postponed the operational date of these projects to January 10, 2028 [4][9] Group 2: Change in Fund Usage - The company plans to use RMB 70.4 million of the uninvested raised funds and its interest income to acquire all partnership interests in beyerdynamic GmbH & Co. KG [6][8] - The acquisition is expected to enhance the company's market competitiveness in the high-end audio sector and align with its strategic goals of high-end manufacturing and brand operation [12][14] Group 3: Financial Impact and Projections - The acquisition is projected to generate RMB 892 million in revenue for the company in 2026, with a gross margin exceeding 50% and a net margin over 10% [12][31] - The transaction is anticipated to significantly improve the company's financial metrics compared to the original investment projects, which had lower expected profitability [12][31] Group 4: Strategic Rationale - The acquisition of beyerdynamic is seen as a strategic move to accelerate the company's transition towards high-end, branded products, enhancing its global market presence [13][30] - The integration of beyerdynamic's established brand and technology is expected to complement the company's existing product lines and manufacturing capabilities, fostering innovation and market expansion [15][32][33]

佳禾智能表示，BD KG是一家全球知名的高端音频设备品牌商和制造商。公司与BD KG同属于电声行 业，双方业务具有较强协同性，通过本次交易，公司可快速提升在高端音频领域的市场竞争力，进一步 提升公司的整体盈利能力。根据评估报告，本次变更2024年向不特定对象发行可转债募集资金用途，有 利于提升募集资金使用效率，有利于提高公司总体资金利用率，符合公司及全体股东的利益。 北京商报讯（记者 马换换 王蔓蕾）8月13日晚间，佳禾智能（300793）披露公告称，公司拟变更部分募 集资金用途。 公告显示，佳禾智能拟使用"年产500万台骨传导耳机项目""年产900万台智能手表项目"及"年产450万台 智能眼镜项目"尚未投入的募集资金7.04亿元及其利息收入、理财收益用于收购beyerdynamic GmbH & Co. KG（以下简称"BD KG"）的全部有限合伙权益，BD KG的普通合伙人BEYER DYNAMIC Verwaltungs-GmbH的全部股份，以及BD KG的股东借款。 ...

此外，鸿达兴业通过虚增营业收入以及虚减营业成本、费用等方式虚增利润总额，导致2020年至 2022年年度报告、2023年半年度报告涉嫌存在虚假记载。上述期间虚增利润总额分别占公司当期披露利 润总额（绝对值）高达94.11%、94.42%、618.70%和12.84%。涉案期间虚增营业收入合计35.05亿元， 虚增利润总额合计40.78亿元。 已从深市退市一年的鸿达兴业股份有限公司（简称"鸿达兴业"，NQ400207）拟被重罚。江苏证监 局日前发出的《行政处罚事先告知书》显示，因涉嫌擅自改变可转债募集资金用途、多年财务造假、重 大诉讼、仲裁未依法披露等事项，江苏证监局拟对鸿达兴业、实控人及7名董监高人员开出合计5800万 元罚单。其中，公司拟被罚1850万元；实控人、董事长兼总经理周奕丰拟被罚2200万元，终身证券市场 禁入；财务总监林桂生拟被罚600万元，10年证券市场禁入。 对于擅自改变可转债募集资金用途、财务造假等严重违法行为，监管部门对鸿达兴业及周奕丰均拟 实施顶格处罚。监管部门认为，周奕丰组织、指使公司在相关定期报告中编造、篡改重要财务数据，严 重扰乱证券市场秩序，组织、指使公司擅自变更募集资金用途； ...

中信证券股份有限公司关于 汤臣倍健股份有限公司 变更部分募集资金用途的核查意见 中信证券股份有限公司（以下简称"中信证券"或"保荐人"）作为汤臣倍 健股份有限公司（以下简称"汤臣倍健"或"公司"）2020 年向特定对象发行股 票的保荐人，根据《证券发行上市保荐业务管理办法》《深圳证券交易所创业板 股票上市规则》《深圳证券交易所上市公司自律监管指引第 2 号——创业板上市 公司规范运作》等规定，对公司变更部分募集资金用途的事项进行了核查，具体 情况如下： 一、募集资金的基本情况 经中国证券监督管理委员会"证监许可[2021]864 号"文核准，公司于 2021 年 4 月向特定对象发行人民币普通股股票 119,288,209 股，发行价格为 26.20 元/ 股，共计募集资金总额为人民币 3,125,351,075.80 元，实际募集资金净额为 普通合伙）、华兴会计师事务所（特殊普通合伙）审验，并出具相关验资报告。 公司对募集资金采取了专户存储管理。 截至 2025 年 6 月 30 日，公司募集资金使用情况如下： | | | | | | | | | 投入金额 | | | 单位：万元 | | | 募集资金承诺 ...

Group 1 - The company held its fifth board meeting of 2025, where all members ensured the accuracy and completeness of the disclosed information [1] - The board approved a proposal to change the use of part of the raised funds from the 2022 stock issuance, reallocating 365.8654 million yuan to a new project focused on green low-carbon technology for data centers [1][2] - The total investment for the new project is 413.9781 million yuan, with the company planning to use 365.8654 million yuan from the raised funds [2] Group 2 - The board agreed to amend certain provisions of the company's articles of association to comply with legal regulations and improve business operations [3][4] - The board also approved revisions to the rules governing shareholder meetings to enhance order and efficiency [3] - The board's decisions, including the amendments to governance structures, will be submitted for approval at the upcoming second extraordinary general meeting of shareholders in 2025 [5]

Core Viewpoint - The company, Diou Home (002798.SZ), plans to adjust the use of funds raised from its convertible bonds, reallocating approximately 477 million yuan to permanently supplement its working capital due to changes in market conditions and operational needs [2][3][4]. Fund Allocation Changes - Diou Home has decided to change the funding purpose of its previously planned projects, specifically the "Oushinou Eight Group Annual Production of 50 Million Square Meters High-End Wall and Floor Tile Intelligent Production Line (Energy Saving and Emission Reduction, Water Saving) Project Phase II" and the "Two Groups Annual Production of 13 Million Square Meters High-End Ceramic Floor Tile Intelligent Production Line Project" [2][3]. - The company had initially raised 1.5 billion yuan through convertible bonds in 2021, with a net amount of approximately 1.482 billion yuan after deducting issuance costs [4]. Operational Adjustments - The decision to repurpose the remaining funds is based on the current market environment and competition, which have significantly changed since the original project plans were made [5][6]. - The company has already utilized 400 million yuan of idle funds to temporarily supplement working capital, which has not yet been repaid [4]. Production Capacity - Diou Home asserts that its current production capacity meets demand, and the new ceramic production lines and technological upgrades have sufficiently addressed the company's needs [5][6]. - The company completed a large-scale high-performance ceramic production line in November 2021, which significantly enhanced its capacity for large-format ceramic slabs [5]. Future Considerations - The company emphasizes the importance of maintaining liquidity to manage potential risks in an uncertain market environment, hence the decision to allocate funds to working capital rather than continuing with the original investment projects [4][5].

Group 1 - The company held its sixth board meeting on July 23, 2025, with all 8 directors present, confirming compliance with legal and regulatory requirements [1] - The board approved a resolution to change the use of raised funds from the public offering of convertible bonds, reallocating surplus funds of 476.5843 million yuan to permanently supplement working capital [2][3] - The board's decision to change the use of funds has been reviewed and approved by the audit and strategy committees and will be submitted for approval at the upcoming shareholder and bondholder meetings scheduled for August 8, 2025 [2][4] Group 2 - The company will terminate the special account for the raised funds after reallocating the remaining funds, and the tripartite supervision agreement with the bank and sponsor will also be terminated [2] - The upcoming shareholder meeting will take place at 14:30 on August 8, 2025, at the company's headquarters in Chengdu, with both in-person and online participation [3][4] - The first bondholder meeting is also scheduled for August 8, 2025, at 15:00, at the same location [4][5]